Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.

Abstract

A 56-year-old woman with Hodgkin-like adult T-cell leukemia/lymphoma was treated with allogeneic peripheral blood stem cell transplantation on 17 April 2009. She manifested a moderate fever on day 41. CT scanning and other examinations detected slightly swollen lymph nodes, and pathological findings of right axillary lymph nodes revealed an Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. She was successfully treated with rituximab.

• Authors: Toshinari Yagi, Jun Ishikawa, Nana Aono, Yukiko Yamashita, Shinsuke Kusakabe, Tetsuhiro Yoshinami, Yuki Akazawa, Daisuke Sakai, Sachiko Yamamoto, Yuri Hamanaka, Hiroaki Masaie, Naotoshi Sugimoto, Hitoshi Yoshida, Yasuhiko Tomita, Fumio Imamura
• Journal: International journal of hematology (Int J Hematol) Vol. 95 Issue 2 Pg. 214-6 (Feb 2012) ISSN: 1865-3774 [Electronic] Japan
• PMID: 22170229 (Publication Type: Case Reports, Journal Article)

Chemical References

• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Agents
• Rituximab

Topics

• Antibodies, Monoclonal, Murine-Derived (therapeutic use)
• Antineoplastic Agents (therapeutic use)
• Epstein-Barr Virus Infections (complications, pathology)
• Female
• Hematopoietic Stem Cell Transplantation
• Humans
• Leukemia-Lymphoma, Adult T-Cell (therapy)
• Lymph Nodes (pathology, virology)
• Lymphoproliferative Disorders (drug therapy, pathology, virology)
• Middle Aged
• Rituximab
• Transplantation, Homologous